A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer.
about
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignanciesInteraction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.Role of Topotecan in Non-Small Cell Lung Cancer: A Review of Literature.
P2860
A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A phase II multicenter study o ...... ed non-small cell lung cancer.
@ast
A phase II multicenter study o ...... ed non-small cell lung cancer.
@en
type
label
A phase II multicenter study o ...... ed non-small cell lung cancer.
@ast
A phase II multicenter study o ...... ed non-small cell lung cancer.
@en
prefLabel
A phase II multicenter study o ...... ed non-small cell lung cancer.
@ast
A phase II multicenter study o ...... ed non-small cell lung cancer.
@en
P2093
P1433
P1476
A phase II multicenter study o ...... ed non-small cell lung cancer.
@en
P2093
D H Garfield
J J Nemunaitis
M A Gregurich
M G Joppert
P Khandelwal
T A Marsland
P304
P356
10.1016/S0169-5002(02)00502-0
P577
2003-02-01T00:00:00Z